Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3208359)

Published in World J Gastroenterol on October 07, 2011

Authors

Ingmar Königsrainer1

Author Affiliations

1: Department of General, Visceral and Transplant Surgery, Tübingen University Hospital, 72076 Tübingen, Germany. ingmar.koenigsrainer@med.uni-tuebingen.de

Articles cited by this

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol (2006) 9.16

Global cancer statistics. CA Cancer J Clin (1999) 8.82

Gastric cancer epidemiology and risk factors. J Clin Epidemiol (2003) 3.94

Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res (1996) 3.00

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol (2007) 2.06

Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol (2008) 1.77

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery. J Surg Oncol (2009) 1.55

Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer (1999) 1.39

Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol (2007) 1.14

Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol (2006) 1.10

Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am (2003) 1.08

PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem (2008) 1.04

Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol (2010) 1.03

Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res (2007) 0.98

(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol (2009) 0.96

Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging. Cell Physiol Biochem (2010) 0.96

A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer (2001) 0.94

Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer (2010) 0.92